Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS): Developing new therapies for chronic obstructive pulmonary disease: lessons learned from the novel D2/β2 agonist, ViozanTM

Bibliographische Detailangaben

Veröffentlicht in:	Respiratory medicine 2003, Vol.97, p.S35-S43
Hauptverfasser:	CELLI, B, HALPIN, D, HEPBURN, R, BYRNE, N, KEATING, E. T, GOLDMAN, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Chronic obstructive pulmonary disease, asthma Medical sciences Pneumology Respiratory system : syndromes and miscellaneous diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!